Proteins such as TSLP, S100A12, IL33, CD244, and TNFB are associated with an elevated risk of AD, suggesting that targeting these proteins may offer potential therapeutic strategies for mitigating AD progression. The gene discussed is IL33; the disease is Alzheimer disease.